- Home
- COEP vs TELA Comparison
COEP vs TELA Comparison
Compare COEP & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- TELA
- Stock Information
- Founded
- COEP 2017
- TELA 2012
- Country
- COEP United States
- TELA United States
- Employees
- COEP N/A
- TELA N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- TELA Medical/Dental Instruments
- Sector
- COEP Health Care
- TELA Health Care
- Exchange
- COEP Nasdaq
- TELA Nasdaq
- Market Cap
- COEP 65.8M
- TELA 70.1M
- IPO Year
- COEP N/A
- TELA 2019
- Fundamental
- Price
- COEP $12.74
- TELA $1.75
- Analyst Decision
- COEP
- TELA Buy
- Analyst Count
- COEP 0
- TELA 3
- Target Price
- COEP N/A
- TELA $5.33
- AVG Volume (30 Days)
- COEP 44.3K
- TELA 97.6K
- Earning Date
- COEP 08-14-2025
- TELA 08-11-2025
- Dividend Yield
- COEP N/A
- TELA N/A
- EPS Growth
- COEP N/A
- TELA N/A
- EPS
- COEP N/A
- TELA N/A
- Revenue
- COEP $263,555.00
- TELA $75,323,000.00
- Revenue This Year
- COEP N/A
- TELA $25.72
- Revenue Next Year
- COEP N/A
- TELA $22.03
- P/E Ratio
- COEP N/A
- TELA N/A
- Revenue Growth
- COEP N/A
- TELA 16.34
- 52 Week Low
- COEP $2.31
- TELA $0.86
- 52 Week High
- COEP $14.70
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- COEP 56.79
- TELA 51.41
- Support Level
- COEP $12.50
- TELA $1.70
- Resistance Level
- COEP $14.09
- TELA $2.00
- Average True Range (ATR)
- COEP 0.92
- TELA 0.19
- MACD
- COEP -0.08
- TELA 0.02
- Stochastic Oscillator
- COEP 55.49
- TELA 65.83
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.